Article
The first Transthyretin Familial Amyloid Polyneuropathy gait quantification study - preliminary results.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference - 1 Jul 2017
Do Carmo Vilas-Boas Maria, Rocha Ana Patricia, Pereira Choupina Hugo Miguel, Fernandes Jose Maria, Coelho Teresa, Silva Cunha Joao Paulo
Abstract excerpt
Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) is a rare neurological disease caused by a genetic mutation with a variable presentation and consequent challenging diagnosis, complex follow-up and treatment. At this moment, this condition has no cure and treatment options are under development. One of the disease's implications is a definite and progressive motor impairment that from the early stages...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.